INS and Insulin resistance: Additionally, an analysis of plasma miR-33b levels in patients with diabetic dyslipidaemia and insulin resistance indicated that miR-33b showed a positive correlation with plasma insulin levels and triglycerides, and a negative tendency with HDL cholesterol; these authors suggested that targeting miR-33b using antisense therapy could help to reduce hyperinsulinemia and prevent low HDL levels [87].